Literature DB >> 6338036

Enzyme-linked immunosorbent assay for Clostridium difficile toxin A.

D M Lyerly, N M Sullivan, T D Wilkins.   

Abstract

Antibodies against Clostridium difficile toxin A were purified by affinity chromatography from antiserum prepared against crude C. difficile toxin preparations. The affinity-purified antibody preparation was free of detectable amounts of antibodies to other C. difficile antigens, as demonstrated by crossed immunoelectrophoresis, and specifically neutralized the cytotoxicity of toxin A. An indirect enzyme-linked immunosorbent assay (ELISA) was subsequently developed using the antibody preparation for the specific detection of toxin A. The ELISA, which could detect 1 ng (5 ng/ml) of toxin A, was used to quantitate the toxin in the culture supernatant fluids of strains of C. difficile. The ELISA values for toxin A closely correlated with the toxin A and B cytotoxic titers of the supernatant fluids. In addition, toxin A was detected by ELISA in human fecal specimens from persons with antibiotic-associated colitis, demonstrating that this toxin is produced during C. difficile colitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6338036      PMCID: PMC272577          DOI: 10.1128/jcm.17.1.72-78.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Diphtheria toxin and related proteins. I. Isolation and properties of mutant proteins serologically related to diphtheria toxin.

Authors:  T Uchida; A M Pappenheimer; R Greany
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

2.  Characterization and genetic mapping of nontoxinogenic (tox) mutants of corynebacteriophage beta.

Authors:  R K Holmes
Journal:  J Virol       Date:  1976-07       Impact factor: 5.103

3.  Enzyme immunoassay for the detection of Clostridium difficile antigen.

Authors:  R H Yolken; L S Whitcomb; G Marien; J D Bartlett; J Libby; M Ehrich; T Wilkins
Journal:  J Infect Dis       Date:  1981-10       Impact factor: 5.226

4.  Detection of Clostridium difficile toxin by counterimmunoelectrophoresis: a note of caution.

Authors:  I R Poxton; M D Byrne
Journal:  J Clin Microbiol       Date:  1981-09       Impact factor: 5.948

5.  Clinical and laboratory observations in Clostridium difficile colitis.

Authors:  J G Bartlett; N S Taylor; T Chang; J Dzink
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

6.  Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters.

Authors:  J G Bartlett; A B Onderdonk; R L Cisneros; D L Kasper
Journal:  J Infect Dis       Date:  1977-11       Impact factor: 5.226

7.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

8.  Clindamycin-induced enterocolitis in hamsters.

Authors:  R H Lusk; R Fekety; J Silva; R A Browne; D H Ringler; G D Abrams
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

9.  Relative frequency of Clostridium difficile in patients with diarrheal disease.

Authors:  P H Gilligan; L R McCarthy; V M Genta
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

Review 10.  Antibiotic-associated pseudomembranous colitis.

Authors:  J G Bartlett
Journal:  Rev Infect Dis       Date:  1979 May-Jun
View more
  54 in total

1.  Localization of two epitopes recognized by monoclonal antibody PCG-4 on Clostridium difficile toxin A.

Authors:  S M Frey; T D Wilkins
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

Authors:  F Müller; C Stiegler; U Hadding
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

3.  Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

Authors:  S P Borriello; T Vale; J S Brazier; S Hyde; E Chippeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

4.  Evaluation of an enzyme immunoassay for detection of Clostridium difficile toxin A.

Authors:  K Tsimidis; A E Simor
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

5.  Toxin A of Clostridium difficile is a potent cytotoxin.

Authors:  K D Tucker; P E Carrig; T D Wilkins
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

6.  Positive regulation of Clostridium difficile toxins.

Authors:  J S Moncrief; L A Barroso; T D Wilkins
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  Molecular characterization of the Clostridium difficile toxin A gene.

Authors:  C H Dove; S Z Wang; S B Price; C J Phelps; D M Lyerly; T D Wilkins; J L Johnson
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

8.  Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters.

Authors:  J F Torres; D M Lyerly; J E Hill; T P Monath
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Effect of various diets on toxin production by two strains of Clostridium difficile in gnotobiotic mice.

Authors:  S Mahe; G Corthier; F Dubos
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

10.  Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-PAGE.

Authors:  M Lahn; G Tyler; W Däubener; U Hadding
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.